Merck rises after third guidance upgrade this year

By Reuters News

** Shares in Merck KGaA MRCG.DE are up around 2% after the German science and technology group raised its 2026 guidance for the third time this year

** Merck now expects EBITDA pre of €6.2 billion-€6.4 billion this year, up from €5.9 billion-€6.3 billion previously, and revenue in €21.5 billion-€21.9 billion range versus €21.0 billion-€21.8 billion previously

** Jefferies notes that both Q3 sales and adjusted EBITDA beat expectations by 3% and 5%, respectively, driven by strong performances in Life Science and Electronics

** The broker says Semi Materials delivered "another record quarter", helping Semiconductor Solutions sales grow 18.7%, well ahead of 9.9% consensus



($1 = 0.9027 euros)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk